🔗 Permalink

Inventor profile of:

David H. Munn

City:

Augusta, Georgia

Country:

United States

Published Applications:

Last publication date:

2018-01-11

Top Assignees for applications by David H. Munn

The entities that hold a legal rights for patent applications filed by inventor Munn David H.:

MEDICAL COLLEGE OF GEORGIA RESEARCH INSTITUTE, INC 3 AUGUSTA, GA United States
GEORGIA HEALTH SCIENCES UNIVERSITY 1 Augusta, GA United States
Med. College of Georgia Research Institute, Inc. 1 Augusta, GA United States
Georgia Health Sciences University Research Institute, Inc. 1 Augusta, GA United States
Regents of the University of Minnesota 1 St. Paul, MN United States
Georfia Regents University 1 August, GA United States

Recent patent applications by Munn David H.

David H. Munn from Augusta, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2018-01-11

US20180008688A1

Human necessities

METHOD AND COMPOSITIONS FOR ENHANCING IMMUNOTHERAPEUTIC TREATMENT OF A CANCER

#2 | 2014-08-21

US20140234373A1

Human necessities

Methods of Promoting Immune Tolerance

#3 | 2013-09-12

US20130236456A1

Chemistry; metallurgy

IMMUNOGLOBULIN Fc FRAGMENT TAGGING ACTIVATION OF ENDOGENOUS CD4 AND CD8 T CELLS AND ENHANCEMENT OF ANTITUMOR EFFECTS OF LENTIVECTOR IMMUNIZATION

#4 | 2012-06-07

US20120141998A1

Chemistry; metallurgy

ANTIGEN-PRESENTING CELL POPULATIONS AND THEIR USE AS REAGENTS FOR ENHANCING OR REDUCING IMMUNE TOLERANCE

#5 | 2011-12-15

US20110305713A1

Chemistry; metallurgy

METHODS AND COMPOSITIONS TO ENHANCE VACCINE EFFICACY BY REPROGRAMMING REGULATORY T CELLS

#6 | 2010-10-21

US20100267042A1

Chemistry; metallurgy

Antigen-Presenting Cell Populations And Their Use As Reagents For Enhancing Or Reducing Immune Tolerance

#7 | 2010-03-04

US20100055111A1

Chemistry; metallurgy

INDOLEAMINE 2,3-DIOXYGENASE, PD-1/PD-L PATHWAYS, AND CTLA4 PATHWAYS IN THE ACTIVATION OF REGULATORY T CELLS

#8 | 2009-02-12

US20090041787A1

Physics

Chemokine receptor antagonists as therapeutic agents

#9 | 2008-12-16

US10660131

Chemokine receptor antagonists as therapeutic agents

#10 | 2007-03-01

US20070048769A1

Chemistry; metallurgy

Kits to assess the risk of tumor progression

#11 | 2006-12-28

US20060292618A1

Chemistry; metallurgy

Antigen-presenting cell populations and their use as reagents for enhancing or reducing immune tolerance

InventorID:

432829 ⎘